INTERNATIONAL PATENT: GENEDITBIO LIMITED FILES APPLICATION FOR "METHODS AND COMPOSITIONS FOR TGFBI GENE EDITING AND THERAPY USING CRISPR SYSTEM AND ENGINEERED PROTEIN DELIVERY VEHICLE"

GENEVA, April 5 -- GENEDITBIO LIMITED (Unit 101-102, 1/F, Building 6W, 6 Science Park West Avenue, HK Science Park, Pak Shek Kok, NTHong Kong) filed a patent application (PCT/CN2025/123635) for "METHODS AND COMPOSITIONS FOR TGFBI GENE EDITING AND THERAPY USING CRISPR SYSTEM AND ENGINEERED PROTEIN DELIVERY VEHICLE" on Sep 24, 2025. With publication no. WO/2026/067458, the details related to the patent application was published on Apr 02, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): JIANG, Zihua (Unit 101-102, 1/F, Building 6W, 6 Science Park West Avenue, HK Science Park, Pak Shek Kok, NTHo...